# A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects

> **NCT01754844** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 57 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** AZD7624
- **DRUG:** Placebo to match

## Key facts

- **NCT ID:** NCT01754844
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2015-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01754844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01754844, "A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01754844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*